ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2023

Efficacy and safety of anlotinib as an adjuvant therapy in hepatocellular carcinoma patients with a high risk of postoperative recurrence.

Jianguo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.